You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 49 No. 6, June 1992 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL CONTRIBUTIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (72)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Immunodiagnosis of Neurocysticercosis

Disappointing Performance of Serology (Enzyme-Linked Immunosorbent Assay) in an Unbiased Sample of Neurological Patients

Manuel Ramos-Kuri, MD; Rosa Maria Montoya, MSc; Alesandro Padilla; Tzipe Govezensky; Maria Luisa Diaz; Eoda Sciutto, PhD; Julio Sotelo, MD; Carlos Larralde, MD

Arch Neurol. 1992;49(6):633-636.


Abstract



• To ascertain the reliability of serological diagnosis of neurocysticercosis in the everyday a priori situation of neurological consultation, the enzyme-linked immunosorbent assay test was used to predict the eventual diagnosis of neurocysticercosis in an unselected sample of 1064 consecutive neurological cases. Results showed 69% sensitivity and 71% specificity of the enzyme-linked immunosorbent assay test for the diagnosis of neurocysticercosis. In sharp contrast with publications that have proclaimed the excellent diagnostic performance of immunodiagnostic tests, our results suggest that identification of serum antibodies with standard enzyme-linked immunosorbent assay techniques is of little value when applied to a large and heterogeneous group of neurological patients in an endemic area of cysticercosis, and our results urge a reevaluation of currently used immunodiagnostic tests that are practiced in the serum of suspected cases.



Author Affiliations



From the National Institute of Neurology and Neurosurgery of Mexico, Mexico City (Drs Ramos-Kuri and Sotelo), and the Institute of Biomedical Investigations, National Autonomous University of Mexico, Mexico City (Drs Sciutto, and Larralde, Mss Montoya, Govezensky, and Díaz, and Mr Padilla).


Footnotes



Accepted for publication December 3, 1991.

Reprint requests to Instituto de Investigaciones Biomédicas, UNAM, Apdo Postal 70228, 04510 México, DF México (Dr Larralde).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Correlation Between the Clinico Radiological Heterogeneity and the Immune-Inflammatory Profiles in Pediatric Patients with Neurocysticercosis from a Tertiary Referral Centre
Kashyap et al.
J Trop Pediatr 2011;0:fmr093v1-fmr093.
ABSTRACT | FULL TEXT  

Human Neurocysticercosis: Comparison of Different Diagnostic Tests Using Cerebrospinal Fluid
Michelet et al.
J. Clin. Microbiol. 2011;49:195-200.
ABSTRACT | FULL TEXT  

Detection of HP10 antigen in serum for diagnosis and follow-up of subarachnoidal and intraventricular human neurocysticercosis
Fleury et al.
J. Neurol. Neurosurg. Psychiatry 2007;78:970-974.
ABSTRACT | FULL TEXT  

Topical Review: Neurocysticercosis in Children
Singhi and Singhi
J Child Neurol 2004;19:482-492.
ABSTRACT  

Characterization of the 8-Kilodalton Antigens of Taenia solium Metacestodes and Evaluation of Their Use in an Enzyme-Linked Immunosorbent Assay for Serodiagnosis
Hancock et al.
J. Clin. Microbiol. 2003;41:2577-2586.
ABSTRACT | FULL TEXT  

SIMILAR DIAGNOSTIC PERFORMANCE FOR NEUROCYSTICERCOSIS OF THREE GLYCOPROTEIN PREPARATIONS FROM TAENIA SOLIUM METACESTODES
VILLOTA et al.
Am J Trop Med Hyg 2003;68:276-280.
ABSTRACT | FULL TEXT  

Proposed diagnostic criteria for neurocysticercosis
Del Brutto et al.
Neurology 2001;57:177-183.
ABSTRACT | FULL TEXT  

Two Epitopes Shared by Taenia crassiceps and Taenia solium Confer Protection against Murine T. crassiceps Cysticercosis along with a Prominent T1 Response
Toledo et al.
Infect. Immun. 2001;69:1766-1773.
ABSTRACT | FULL TEXT  

Neurocysticercosis and epilepsy in developing countries
Pal et al.
J. Neurol. Neurosurg. Psychiatry 2000;68:137-143.
ABSTRACT | FULL TEXT  

Serological Diagnosis of Human Cysticercosis by Use of Recombinant Antigens from Taenia solium Cysticerci
Hubert et al.
CVI 1999;6:479-482.
ABSTRACT | FULL TEXT  

Towards a Taenia solium Cysticercosis Vaccine: an Epitope Shared by Taenia crassiceps and Taenia solium Protects Mice against Experimental Cysticercosis
Toledo et al.
Infect. Immun. 1999;67:2522-2530.
ABSTRACT | FULL TEXT  

Cysticercosis: Clinical Classification Based on Imaging Studies
Salgado et al.
Arch Intern Med 1997;157:1991-1997.
ABSTRACT  

Is the Course of Neurocysticercosis Modified by Treatment With Antihelminthic Agents?
Carpio et al.
Arch Intern Med 1995;155:1982-1988.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.